Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 2020: Analysis from BIOSTAT-CHF
Added: 3 years ago
Dr Gad Cotter (Momentum Research, Durham, NC, US) and Dr Beth Davison (Momentum Research, Durham, NC, US) discuss an analysis of BIOSTAT-CHF to determine Acute Heart Failure as a distinctive disorder. Questions: 1. Can you briefly remind us of BIOSTAT-CHF? 2. What was the rationale for this analysis? 3. What was the design of this analysis? 4. What were the end-points? Were they met? 5. What… View more

Heart Failure
Antoni Bayés-Genís
Job title: Head of the Cardiology Department
Dr Antoni Bayés-Genís is Professor of Cardiology at the Universitat Autònoma de Barcelona, Spain and Head of the Cardiology Department at the University Hospital Germans Trias i Pujol, Barcelona. Dr Bayés-Genís is also an expert on biomarker, including natriuretic peptides ST2 and neprilysin, having lectured on the subject at numerous international meetings and generated research data that… View more
Stephen Greene
Job title: Assistant Professor, Advanced Heart Failure & Transplantation
Dr Stephen Greene is Assistant Professor in Advanced Heart Failure & Transplantation atThe Duke University School of Medicine inDurham, North Carolina, US. Dr Greene isa cardiologist with a clinical and research interest in heart failure. Hisresearch interests are focused on strategies and therapies to improve outcomes and quality of life for patients with heart failure. This involves research… View more
Clozapine-induced Cardiomyopathy: A Case Report
Author(s): Essa Hariri , Anna Scandinaro , Mazen M Al Hammoud , et al Added: 1 year ago

Heart Failure
ACC 23: Mechanism of Benefit for Dapagliflozin in HFpEF
Author(s): Barry Borlaug Added: 1 year ago
ACC.23/WCC —In this short interview from the ACC's 2023 Scientific Sessions, Dr Barry Borlaug (Mayo Clinic, US) joins us virtually to discuss a trial which aims to evaluate the mechanism of benefit for dapagliflozin in patients with heart failure with preserved ejection fraction (Mayo Clinic). The study was conducted over 6 months with 43 patients enrolled in the trial. The main findings suggest… View more

Heart Failure
ESC-HFA 2023: Late-Breaking Science Video Collection
Author(s): Jasper J Brugts , Ahmad Masri , Marianna Fontana , et al Added: 11 months ago
Get the most out of the new data from, Late-breaker host, Dr Harriette Van Spall and Dr James Januzzi wrap up of the most impactful trials and studies presented at Heart Failure 2023. Delve into in-depth and critical discussions with Dr Van Spall in our thought-provoking Late-breaker Discussion series. For concise and practical take-home messages for practice and cardiovascular research… View more

Standards & Guidelines

Heart Failure
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi
Author(s): Harriette Van Spall , James L Januzzi Added: 11 months ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure. Trials covered in details include: 1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy 1:42: TRACER-HF:Trientine-HCL for treatment of… View more

Standards & Guidelines

Heart Failure
AHA 2021 Late-breaker Discussion: The EMPULSE Trial
Author(s): Harriette Van Spall , Adriaan A Voors Added: 2 years ago
In this in-depth conversational interview, Late-breaker host Dr Harriette Van Spall (McMaster University, CA) meets PI, Prof Adriaan Voors (University Medical Center Groningen, NL) to discuss the EMPULSE trial. The aim of the trial was to evaluate empagliflozin compared with placebo among patients with acute decompensated heart failure. Presented first at AHA 2021, the trial showed that that… View more

Heart Failure
AHA 2021: Late-breaking Science Video Collection
Author(s): Anushka Patel , Stephen Nicholls , Jeffrey Weitz , et al Added: 2 years ago
Our regular review seriesView from the Thoraxcenterhosted by Prof Nicolas Van MieghemandDr Joost Daemen provide aconcise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021. For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators. Short, accessibleExpert Interviewswill be… View more

Vascular Disease and Surgery

Standards & Guidelines
Optimizing GDMT for HFrEF During Hospitalization
Author(s): Neal M Dixit , Shivani Shah , Boback Ziaeian , et al Added: 2 years ago

Heart Failure